2-(Tetrazol-5-yl)phenylboronic Acid acts as a reagent in the synthesis of (biphenylmethyl)pyridone and (pyridylmethyl)pyridone pharmaceuticals for the treatment of glaucoma and diabetic retinopathy. Also acts as a reagent for the preparation of sartan drug intermediates. Sartans are agiotensin receptor blockers.
Thermal decomposition of 2-(2H-Tetrazol-5-yl)-phenylboronic acid can lead to release of irritating gases and vapors, Carbon monoxide (CO), Carbon dioxide (CO2), Oxides of boron, Nitrogen oxides (NOx)